Clay Siegall Fight Against Cancer

November 5th, 2017

Clay Siegall is the founder of Seattle Genetics a biotechnology company located in Seattle, Washington, in the U.S., and an author of over 70 publications and 15 patents. Seattle Genetics is one of the largest biotechnology companies in Washington. Clay founded Seattle Genetics in the year 1998, and it has become a success with the motivation of one of his mentors in the laboratory who always encouraged him not to take a ‘No’ for an answer. Currently, Seattle Genetics has 900 employees with a market value of about $10 billion, with an ambition of adding another 200 employees and becoming a big pharm.

Clay worked for the National Institutes of Health and Bristol-Myers Squibb Pharmaceutical Research Institute, which gave him experience in research. Apart from working in his Company, Clay works for Alder Biopharmaceuticals as a member of the board of directors. Through his leadership, the company has been able to achieve its ambitions and success by being an emerging multiproduct, an oncology company in the globe.

Seattle Genetics has been able to provide antibody-based cancer therapies by studying, manipulating and packaging them as drugs. Seattle Genetics always invests in marketing and research to achieve its success and ambitions. Through the research they have carried out, they have been able to come up with a variety of drugs thus made it a bigger company.

Clay is always interested in marketing their new drugs in the international market than focusing on drug development. Because of his interest, they have been able to open an office in Switzerland for them to be able to do international marketing. Another evidence was when Clay put a bid to spend 2 billion dollars to get global rights to commercialize a particular cancer drug that was developed by New Jersey-based Immunomedics but was later denied by a judge.

Seattle Genetics has grown in the past years since its development, and recently it was able to make $418 million sales. That shows it will be able to make a bigger profit in the future. Some of the drugs that have resulted in the growth of this company are Adcetris that has been approved by FDA as a drug that can treat Hodgkin lymphoma, and it is used when patients do not get any response once they take any drugs. The drug is said to be used by oncologists once it proves its ability and it would result in almost 1billion dollar sales.

ADC is another drug that Seattle Genetics has focused on most, and it’s used to boost the production of antibodies, it’s known to kill cancer cells. Other drugs produced by Seattle Genetics are 33A, 22ME, and LIV1. These drugs have enabled this company to achieve its aimed success; especially to do away with cancer.

In as much as Clay loves making drugs, he says it’s never easy but tries to achieve his goals. He became a successful entrepreneur by using Art Levinson strategies he used in Genetech, especially the production of multi-products. Most investors turned him down, but he never gave up, but instead worked hard to achieve his success.

Leave a Reply

You must be logged in to post a comment.